This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
VISION Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
mHSPC
ARASENS Trial
nmCRPC
ARAMIS Trial
PSMA PET Imaging
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
Centers of Excellence
Urologic Oncology
Left Group
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Petros Grivas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Kidney Cancer Today
Sumanta (Monty) Kumar Pal, MD
Jaime Landman, MD
Prostate Cancer
Advanced Prostate Cancer
Alicia Morgans, MD, MPH
CRPC with Bone Metastases
Rana R. McKay, MD
Imaging Center
Phillip Koo, MD
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
mHSPC
Alicia Morgans, MD, MPH
nmCRPC
Alicia Morgans, MD, MPH
PSMA-Targeted Therapy
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular, Penile, and Rare GU Malignancies
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Education
Covid-19
The Prostate Cancer Foundation
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Pelvic Health & Reconstruction
Endourology
Testicular Cancer
Clinical Trials
From the Editor
Search Clinical Trials
Transformative Trials
DORA - PCCTC
IRONMAN - PCCTC
PROMISE - PCCTC
SPLASH Trial
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
RSNA 2022
SUO 2022
Urologists for Social Responsibility 2023
Upcoming
ASCO GU 2023
All Conferences
View All
PCF
UroToday Home
Conference Highlights
EMUC 2020
EMUC 2020
GU Malignancies Prostate
GU Malignancies Non-Prostate
EMUC 2020 GU Malignancies Non-Prostate
Viewing 1-20 of 23 articles
EMUC 2020: Hybrid ICG - 99mTc - Nanocolloid, on the Road Towards Becoming the New Standard for Sentinel Node Biopsy in Penile Cancer
EMUC 2020: Organ Preservation in Challenging Cases - Penile Cancer
EMUC 2020: A Subgroup Analysis from the IMvigor130 Study in Patients with Upper Tract vs. Lower Tract Locally Advanced or Metastatic Urothelial Carcinoma Treated with Atezolizumab plus Platinum - Based Chemotherapy
EMUC 2020: Adjuvant Strategies in Locally Advanced Bladder Cancer
EMUC 2020: Organ Preservation in Bladder Cancer (Trimodal vs Cystectomy)
EMUC 2020: Organ Preservation in Challenging Cases - Testicular Cancer
EMUC 2020: Molecular Sub-Staging of Bladder Cancer: Is It Really Useful?
EMUC 2020: Kidney Sparing in Upper Tract Urothelial Cancer
EMUC 2020: Partial Nephrectomy in T2 Tumors, Renal Cell Carcinoma
EMUC 2020: Neoadjuvant Versus Adjuvant Strategies in Locally Advanced Bladder Cancer
EMUC 2020: Management and Survival of Patients with Retroperitoneal Recurrences Following Radical Nephrectomy
EMUC 2020: Molecular Subtypes of Fully Resected Clear Cell Renal Cell Carcinoma Are Prognostic for Risk of Relapse and May Impact Adjuvant Treatment
EMUC 2020: VIRADS - Can We Avoid TUR-B Prior to Radical Cystectomy?
EMUC 2020: COVID-19 and GU Cancer Care: The Radiation Oncologist's Experience
EMUC 2020: The COVID-19 Pandemic: The Urologist's Experience
EMUC 2020: COVID-19 and GU Cancer Care: The Medical Oncologist's Experience
EMUC 2020: Optimal First Line Therapy in Metastatic Bladder Cancer Disease
EMUC 2020: Recommendations During COVID-19 from the EAU Guidelines Office Rapid Reaction Group
EMUC 2020: Durvalumab Monotherapy or in Combination with Tremelimumab Versus Standard of Care Chemotherapy in Patients with Advanced Urothelial Carcinoma, The DANUBE Trial
EMUC 2020: Standard BCG vs Reduced Frequency BCG in Non-Muscle Invasive Bladder Cancer, The NIMBUS Trial
1
2
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free